11月 2025
- 首頁
- Neuronetics
11月 2025Neuronetics的市場佔有率分析
Antidepressant medications don't work for everyone. If drugs haven't worked for you, learn about NeuroStar - safe, effective, lasting TMS therapy for depression.
Neuronetics(包含公司地區)
查看更多網站流量與參與度資訊- neuronetics.com
Neuronetics的熱門網域總造訪量
了解Neuronetics市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Neuronetics的熱門網域平均造訪時長
分析Neuronetics參與度指標。
過去 3 個月平均造訪時長
子公司細目
Neuronetics的熱門網域平均頁面瀏覽量
了解Neuronetics如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Neuronetics
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Neuronetics, Inc. attends event Piper Sandler 37th Annual Healthcare Conference.Neuronetics to participate at the Piper Sandler 37th Annual Healthcare Conference.
11月 20, 2025閱讀更多
新聞Neuronetics, Inc. partners with Elitednatherapy.Neuronetics announces three-year exclusive partnership with Elite DNA Behavioral Health to expand NeuroStar access and operational excellence.
10月 30, 2025閱讀更多
新聞Neuronetics, Inc. attended event Canaccord Genuity 45th Annual Growth Conference on Aug 12th '25.MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) - Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that Keith Sullivan, President and Chief Executive Officer, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025.
8月 4, 2025閱讀更多
查看所有Neuronetics信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。